0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-13C13054
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Gene Therapy Sales Market Report 2023
BUY CHAPTERS

Global Gene Therapy Market Research Report 2024

Code: QYRE-Auto-13C13054
Report
January 2024
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Therapy Market Size

The global Gene Therapy market was valued at US$ 7077.6 million in 2023 and is anticipated to reach US$ 39700 million by 2030, witnessing a CAGR of 27.6% during the forecast period 2024-2030.

Gene Therapy Market

Gene Therapy Market

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy.

Report Scope

The Gene Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Therapy Market Report

Report Metric Details
Report Name Gene Therapy Market
Accounted market size in 2023 US$ 7077.6 million
Forecasted market size in 2030 US$ 39700 million
CAGR 27.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Viral Gene Therapy
  • Non-Viral Gene Therapy
Segment by Application
  • Neurological Diseases
  • Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gene Therapy Market growing?

Ans: The Gene Therapy Market witnessing a CAGR of 27.6% during the forecast period 2024-2030.

What is the Gene Therapy Market size in 2030?

Ans: The Gene Therapy Market size in 2030 will be US$ 39700 million.

What is the market share of major companies in Gene Therapy Market?

Ans: Global top three manufacturers hold a share about 75%.

Who are the main players in the Gene Therapy Market report?

Ans: The main players in the Gene Therapy Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the Gene Therapy Market report?

Ans: The Applications covered in the Gene Therapy Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the Gene Therapy Market report?

Ans: The Types covered in the Gene Therapy Market report are Viral Gene Therapy, Non-Viral Gene Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2019-2030)
2.2 Gene Therapy Growth Trends by Region
2.2.1 Global Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Therapy Historic Market Size by Region (2019-2024)
2.2.3 Gene Therapy Forecasted Market Size by Region (2025-2030)
2.3 Gene Therapy Market Dynamics
2.3.1 Gene Therapy Industry Trends
2.3.2 Gene Therapy Market Drivers
2.3.3 Gene Therapy Market Challenges
2.3.4 Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Players by Revenue
3.1.1 Global Top Gene Therapy Players by Revenue (2019-2024)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Revenue
3.4 Global Gene Therapy Market Concentration Ratio
3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2023
3.5 Gene Therapy Key Players Head office and Area Served
3.6 Key Players Gene Therapy Product Solution and Service
3.7 Date of Enter into Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Breakdown Data by Type
4.1 Global Gene Therapy Historic Market Size by Type (2019-2024)
4.2 Global Gene Therapy Forecasted Market Size by Type (2025-2030)
5 Gene Therapy Breakdown Data by Application
5.1 Global Gene Therapy Historic Market Size by Application (2019-2024)
5.2 Global Gene Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Therapy Market Size (2019-2030)
6.2 North America Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Therapy Market Size by Country (2019-2024)
6.4 North America Gene Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy Market Size (2019-2030)
7.2 Europe Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Therapy Market Size by Country (2019-2024)
7.4 Europe Gene Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Market Size (2019-2030)
8.2 Asia-Pacific Gene Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy Market Size (2019-2030)
9.2 Latin America Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Therapy Market Size by Country (2019-2024)
9.4 Latin America Gene Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Market Size (2019-2030)
10.2 Middle East & Africa Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy Introduction
11.1.4 Biogen Revenue in Gene Therapy Business (2019-2024)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy Introduction
11.2.4 Novartis Revenue in Gene Therapy Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2019-2024)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2019-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy Introduction
11.6.4 Amgen Revenue in Gene Therapy Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy Introduction
11.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2019-2024)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2019-2024)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy Introduction
11.9.4 bluebird bio Revenue in Gene Therapy Business (2019-2024)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy Business (2019-2024)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Gene Therapy Business (2019-2024)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy Introduction
11.12.4 AnGes Revenue in Gene Therapy Business (2019-2024)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2019-2024)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2019-2024)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Viral Gene Therapy
    Table 3. Key Players of Non-Viral Gene Therapy
    Table 4. Global Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Gene Therapy Market Share by Region (2019-2024)
    Table 8. Global Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Gene Therapy Market Share by Region (2025-2030)
    Table 10. Gene Therapy Market Trends
    Table 11. Gene Therapy Market Drivers
    Table 12. Gene Therapy Market Challenges
    Table 13. Gene Therapy Market Restraints
    Table 14. Global Gene Therapy Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Gene Therapy Market Share by Players (2019-2024)
    Table 16. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2023)
    Table 17. Ranking of Global Top Gene Therapy Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Therapy Product Solution and Service
    Table 21. Date of Enter into Gene Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Therapy Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Gene Therapy Revenue Market Share by Type (2019-2024)
    Table 25. Global Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Gene Therapy Revenue Market Share by Type (2025-2030)
    Table 27. Global Gene Therapy Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Gene Therapy Revenue Market Share by Application (2019-2024)
    Table 29. Global Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Gene Therapy Revenue Market Share by Application (2025-2030)
    Table 31. North America Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Gene Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Gene Therapy Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Biogen Company Detail
    Table 47. Biogen Business Overview
    Table 48. Biogen Gene Therapy Product
    Table 49. Biogen Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 50. Biogen Recent Development
    Table 51. Novartis Company Detail
    Table 52. Novartis Business Overview
    Table 53. Novartis Gene Therapy Product
    Table 54. Novartis Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 55. Novartis Recent Development
    Table 56. Gilead Sciences Company Detail
    Table 57. Gilead Sciences Business Overview
    Table 58. Gilead Sciences Gene Therapy Product
    Table 59. Gilead Sciences Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 60. Gilead Sciences Recent Development
    Table 61. Sarepta Therapeutics Company Detail
    Table 62. Sarepta Therapeutics Business Overview
    Table 63. Sarepta Therapeutics Gene Therapy Product
    Table 64. Sarepta Therapeutics Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 65. Sarepta Therapeutics Recent Development
    Table 66. Alnylam Pharmaceuticals Company Detail
    Table 67. Alnylam Pharmaceuticals Business Overview
    Table 68. Alnylam Pharmaceuticals Gene Therapy Product
    Table 69. Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 70. Alnylam Pharmaceuticals Recent Development
    Table 71. Amgen Company Detail
    Table 72. Amgen Business Overview
    Table 73. Amgen Gene Therapy Product
    Table 74. Amgen Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 75. Amgen Recent Development
    Table 76. Spark Therapeutics Company Detail
    Table 77. Spark Therapeutics Business Overview
    Table 78. Spark Therapeutics Gene Therapy Product
    Table 79. Spark Therapeutics Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 80. Spark Therapeutics Recent Development
    Table 81. Akcea Therapeutics Company Detail
    Table 82. Akcea Therapeutics Business Overview
    Table 83. Akcea Therapeutics Gene Therapy Product
    Table 84. Akcea Therapeutics Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 85. Akcea Therapeutics Recent Development
    Table 86. bluebird bio Company Detail
    Table 87. bluebird bio Business Overview
    Table 88. bluebird bio Gene Therapy Product
    Table 89. bluebird bio Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 90. bluebird bio Recent Development
    Table 91. Sunway Biotech Company Detail
    Table 92. Sunway Biotech Business Overview
    Table 93. Sunway Biotech Gene Therapy Product
    Table 94. Sunway Biotech Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 95. Sunway Biotech Recent Development
    Table 96. SIBIONO Company Detail
    Table 97. SIBIONO Business Overview
    Table 98. SIBIONO Gene Therapy Product
    Table 99. SIBIONO Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 100. SIBIONO Recent Development
    Table 101. AnGes Company Detail
    Table 102. AnGes Business Overview
    Table 103. AnGes Gene Therapy Product
    Table 104. AnGes Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 105. AnGes Recent Development
    Table 106. Orchard Therapeutics Company Detail
    Table 107. Orchard Therapeutics Business Overview
    Table 108. Orchard Therapeutics Gene Therapy Product
    Table 109. Orchard Therapeutics Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 110. Orchard Therapeutics Recent Development
    Table 111. Human Stem Cells Institute Company Detail
    Table 112. Human Stem Cells Institute Business Overview
    Table 113. Human Stem Cells Institute Gene Therapy Product
    Table 114. Human Stem Cells Institute Revenue in Gene Therapy Business (2019-2024) & (US$ Million)
    Table 115. Human Stem Cells Institute Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Gene Therapy Market Share by Type: 2023 VS 2030
    Figure 3. Viral Gene Therapy Features
    Figure 4. Non-Viral Gene Therapy Features
    Figure 5. Global Gene Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Gene Therapy Market Share by Application: 2023 VS 2030
    Figure 7. Neurological Diseases Case Studies
    Figure 8. Cancer Case Studies
    Figure 9. Other Case Studies
    Figure 10. Gene Therapy Report Years Considered
    Figure 11. Global Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Gene Therapy Market Share by Region: 2023 VS 2030
    Figure 14. Global Gene Therapy Market Share by Players in 2023
    Figure 15. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2023
    Figure 17. North America Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Gene Therapy Market Share by Country (2019-2030)
    Figure 19. United States Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Gene Therapy Market Share by Country (2019-2030)
    Figure 23. Germany Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Gene Therapy Market Share by Region (2019-2030)
    Figure 31. China Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Gene Therapy Market Share by Country (2019-2030)
    Figure 39. Mexico Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Gene Therapy Market Share by Country (2019-2030)
    Figure 43. Turkey Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Biogen Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 46. Novartis Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 47. Gilead Sciences Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 48. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 50. Amgen Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 51. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 52. Akcea Therapeutics Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 53. bluebird bio Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 54. Sunway Biotech Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 55. SIBIONO Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 56. AnGes Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 57. Orchard Therapeutics Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 58. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy Business (2019-2024)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-24R5886
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Congenital Heart Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29D6035
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Gardner Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28H13051
Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Drugs for Alport Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-16A13427
Tue Mar 26 00:00:00 UTC 2024

Add to Cart